Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Oct, 2019 | Pages:
110 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)
The global non-opioid pain patches market size is expected to reach USD 1.04 billion by 2026, expanding at a CAGR of 4.6% during the forecast period, according to a new report by Grand View Research, Inc. Some of the key factors driving the market are rising incidence of pain related disorders and the various benefits offered by these patches over other forms of medication used to alleviate acute and chronic pain. According to the AAPM, chronic pain affects more individuals than cancer, diabetes, and coronary heart disease combined in the U.S. Estimates from the American Chiropractic Association indicate that American citizens spend at least USD 50 billion every year on back-related ailments. These facts are indicative of the growing need for therapies to alleviate pain globally. Opioid medications are usually sought for the treatment of pain and related disorders despite resulting in dependence and abuse in majority of patients. The rising addiction to opioid drugs has encouraged many countries to develop alternate therapies to alleviate discomfort. In November 2017, opioid epidemic in the U.S. was declared as a national emergency. Thus, demand for safe and effective therapies that ease the underlying discomfort with reduced adverse effects are sought by governments, thus accelerating the market growth. According to a new study published by Substance Abuse and Mental Health Services Administration report in 2015, 1 in 3 adults in America were prescribed painkillers by medical providers. Statistics from the same source also indicate that these medications were used more than cigarettes, cigars, and smokeless tobacco combined. Most of these oral medicines fall under the opiate category are usually more prone to be addictive and used in combination with other consumables such as alcohol and other drugs. Growing awareness about the adverse effects associated with these drugs has led to the development of alternatives such as non-opioid pain patches to deliver the same therapeutic effect and aid in pain management. Further key findings from the study suggest: • Methyl salicylate patches are expected to gain significant revenue during the forecast period owing to increase in product penetration and consumer adoption • North America held the largest revenue share due to local presence of major non-opioid pain patch market players and increasing R&D in the field of pain management to cater to a rising number of patients • The Asia Pacific region is expected to account for the highest CAGR during the forecast period owing to rise in investments by dominant players in the region and developments in the pharmaceutical industry in emerging countries such as India and China
Table of Contents
Chapter 1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.4 Purchased database
1.5 GVR's internal database
1.6 Secondary sources & third party perspectives
1.7 Primary research
1.8 Information analysis
1.9 Data analysis models
1.10 Market formulation & data visualization
1.11 Data validation & publishing
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Non-opioid Pain Patches Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.2.1 User perspective analysis
3.2.1.1 Consumer behavior analysis
3.3 Regulatory Framework
3.3.1 Reimbursement framework
3.3.2 Standards and compliances
3.4 Market Dynamics
3.4.1 Market driver analysis
3.4.1.1 Increasing use of opioid prescriptions
3.4.1.2 Increasing incidence of pain related disorders
3.4.1.3 Benefits offered by non-opioid pain patches over other forms of medication
3.4.2 Market Restraint Analysis
3.4.2.1 Side effects caused by prolonged use of non-opioid pain patches
3.4.3 Market Opportunity Analysis
3.4.3.1 Development of patches without side effects
3.4.4 Market Challenge Analysis
3.4.4.1 Addiction caused by non-opioid pain patches
3.4.4.2 Low adoption rate
3.4.4.3 Use of implants
3.5 Non-opioid Pain Patches Market Analysis Tools
3.5.1 Industry analysis - Porter's
3.5.1.1 Supplier Power
3.5.1.2 Buyer Power
3.5.1.3 Substitution Threat
3.5.1.4 Threat from new entrants
3.5.1.5 Competitive Rivalry
3.5.2 PESTEL Analysis
3.5.2.1 Political Landscape
3.5.2.2 Environmental Landscape
3.5.2.3 Social landscape
3.5.2.4 Services landscape
3.5.2.5 Legal Landscape
3.5.3 Major deals and strategic alliances analysis
3.5.3.1 Joint ventures
3.5.3.2 Mergers and acquisitions
3.5.3.3 Licensing and partnership
3.5.3.4 Services collaborations
3.5.3.5 Strategic Divestments
Chapter 4 Non-opioid Pain Patches Market - Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company Categorization
4.2.1 List of key distributors and channel partners
4.2.2 Key company market share analysis, 2018
4.3 Public Companies
4.3.1 Company market position analysis
4.4 Private Companies
4.4.1 List of key emerging companies
4.4.2 Regional network map
4.4.3 Company market position analysis
Chapter 5 Non-opioid Pain Patches Market: Patch Type Estimates and Trend Analysis
5.1 Definition & Scope
5.2 Patch Type Market Share Analysis, 2018 & 2026
5.3 Segment Dashboard
5.4 Global Non-opioid Pain Patches Market, by Patch Type, 2015 to 2026
5.5 Market Size & Forecasts and Trend Analyses, 2015 to 2026
5.6 Lidocaine Patches
5.6.1 Lidocaine Patches Market, 2015 to 2026 (USD Million)
5.7 Diclofenac Patches
5.7.1 Diclofenac Patches Market, 2015 to 2026 (USD Million)
5.8 Methyl Salicylate Patches
5.8.1 Methyl Salicylate Patches Market, 2015 to 2026 (USD Million)
5.9 Capsaicin Patches
5.9.1 Capsaicin Patches Market, 2015 to 2026 (USD Million)
5.10 Ketoprofen Patches
5.10.1 Ketoprofen Patches Market, 2015 to 2026 (USD Million)
Chapter 6 Non-opioid Pain Patches Market: Distribution Type Estimates and Trend Analysis
6.1 Definition & Scope
6.2 Distribution Type Market Share Analysis, 2018 & 2026
6.3 Segment Dashboard
6.4 Global Non-opioid Pain Patches Market, by Distribution Type, 2015 to 2026
6.5 Market Size & Forecasts and Trend Analyses, 2015 to 2026
6.6 Hospital Pharmacies
6.6.1 Hospital Pharmacies Market, 2015 to 2026 (USD Million)
6.7 Online Pharmacies
6.7.1 Online Pharmacies Market, 2015 to 2026 (USD Million)
6.8 Drug Stores
6.8.1 Drug Stores Market, 2015 to 2026 (USD Million)
Chapter 7 Non-opioid Pain Patches Market: Regional Estimates & Trend Analysis
7.1 Regional Market Snapshot
7.2 Market Share Analysis by Country, 2018
7.2.1 North America
7.2.1.1 U.S.
7.2.1.2 Canada
7.2.2 Europe
7.2.2.1 UK
7.2.2.2 Germany
7.2.2.3 Spain
7.2.2.4 France
7.2.2.5 Italy
7.2.2.6 Russia
7.2.3 Latin America
7.2.3.1 Brazil
7.2.3.2 Mexico
7.2.3.3 Argentina
7.2.4 Asia Pacific
7.2.4.1 Japan
7.2.4.2 China
7.2.4.3 India
7.2.4.4 South Korea
7.2.4.5 Australia
7.2.5 Middle East & Africa
7.2.5.1 South africa
7.2.5.2 Saudi Arabia
7.2.5.3 UAE
7.3 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.3.1 North America
7.3.2 Europe
7.3.3 Latin America
7.3.4 Asia Pacific
7.3.5 Middle East & Africa
7.4 Market Size & Forecasts, and Trend Analysis, 2018 to 2026
7.4.1 North America
7.4.1.1 North America Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.4.1.2 U.S.
7.4.1.2.1 Market Size & Forecasts and Trend Analysis, By Patch Type, 2015 to 2026 (USD Million)
7.4.1.2.2 Market Size & Forecasts and Trend Analysis, By Distribution Type, 2015 to 2026 (USD Million)
7.4.1.3 Canada
7.4.1.3.1 Market Size & Forecasts and Trend Analysis, By Patch Type, 2015 to 2026 (USD Million)
7.4.1.3.2 Market Size & Forecasts and Trend Analysis, By Distribution Type, 2015 to 2026 (USD Million)
7.4.2 Europe
7.4.2.1 Europe Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.4.2.2 UK
7.4.2.2.1 Market Size & Forecasts and Trend Analysis, By Patch Type, 2015 to 2026 (USD Million)
7.4.2.2.2 Market Size & Forecasts and Trend Analysis, By Distribution Type, 2015 to 2026 (USD Million)
7.4.2.3 Germany
7.4.2.3.1 Market Size & Forecasts and Trend Analysis, By Patch Type, 2015 to 2026 (USD Million)
7.4.2.3.2 Market Size & Forecasts and Trend Analysis, By Distribution Type, 2015 to 2026 (USD Million)
7.4.2.4 Spain
7.4.2.4.1 Market Size & Forecasts and Trend Analysis, By Patch Type, 2015 to 2026 (USD Million)
7.4.2.4.2 Market Size & Forecasts and Trend Analysis, By Distribution Type, 2015 to 2026 (USD Million)
7.4.2.5 France
7.4.2.5.1 Market Size & Forecasts and Trend Analysis, By Patch Type, 2015 to 2026 (USD Million)
7.4.2.5.2 Market Size & Forecasts and Trend Analysis, By Distribution Type, 2015 to 2026 (USD Million)
7.4.2.6 Italy
7.4.2.6.1 Market Size & Forecasts and Trend Analysis, By Patch Type, 2015 to 2026 (USD Million)
7.4.2.6.2 Market Size & Forecasts and Trend Analysis, By Distribution Type, 2015 to 2026 (USD Million)
7.4.2.7 Russia
7.4.2.7.1 Market Size & Forecasts and Trend Analysis, By Patch Type, 2015 to 2026 (USD Million)
7.4.2.7.2 Market Size & Forecasts and Trend Analysis, By Distribution Type, 2015 to 2026 (USD Million)
7.4.3 Latin America
7.4.3.1 Latin America Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.4.3.2 Brazil
7.4.3.2.1 Market Size & Forecasts and Trend Analysis, By Patch Type, 2015 to 2026 (USD Million)
7.4.3.2.2 Market Size & Forecasts and Trend Analysis, By Distribution Type, 2015 to 2026 (USD Million)
7.4.3.3 Mexico
7.4.3.3.1 Market Size & Forecasts and Trend Analysis, By Patch Type, 2015 to 2026 (USD Million)
7.4.3.3.2 Market Size & Forecasts and Trend Analysis, By Distribution Type, 2015 to 2026 (USD Million)
7.4.3.4 Argentina
7.4.3.4.1 Market Size & Forecasts and Trend Analysis, By Patch Type, 2015 to 2026 (USD Million)
7.4.3.4.2 Market Size & Forecasts and Trend Analysis, By Distribution Type, 2015 to 2026 (USD Million)
7.4.4 Asia Pacific
7.4.4.1 Asia Pacific Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.4.4.2 Japan
7.4.4.2.1 Market Size & Forecasts and Trend Analysis, By Patch Type, 2015 to 2026 (USD Million)
7.4.4.2.2 Market Size & Forecasts and Trend Analysis, By Distribution Type, 2015 to 2026 (USD Million)
7.4.4.3 China
7.4.4.3.1 Market Size & Forecasts and Trend Analysis, By Patch Type, 2015 to 2026 (USD Million)
7.4.4.3.2 Market Size & Forecasts and Trend Analysis, By Distribution Type, 2015 to 2026 (USD Million)
7.4.4.4 India
7.4.4.4.1 Market Size & Forecasts and Trend Analysis, By Patch Type, 2015 to 2026 (USD Million)
7.4.4.4.2 Market Size & Forecasts and Trend Analysis, By Distribution Type, 2015 to 2026 (USD Million)
7.4.4.5 South Korea
7.4.4.5.1 Market Size & Forecasts and Trend Analysis, By Patch Type, 2015 to 2026 (USD Million)
7.4.4.5.2 Market Size & Forecasts and Trend Analysis, By Distribution Type, 2015 to 2026 (USD Million)
7.4.4.6 Australia
7.4.4.6.1 Market Size & Forecasts and Trend Analysis, By Patch Type, 2015 to 2026 (USD Million)
7.4.4.6.2 Market Size & Forecasts and Trend Analysis, By Distribution Type, 2015 to 2026 (USD Million)
7.4.5 Middle East & Africa
7.4.5.1 Middle East & Africa Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.4.5.2 South Africa
7.4.5.2.1 Market Size & Forecasts and Trend Analysis, By Patch Type, 2015 to 2026 (USD Million)
7.4.5.2.2 Market Size & Forecasts and Trend Analysis, By Distribution Type, 2015 to 2026 (USD Million)
7.4.5.3 Saudi Arabia
7.4.5.3.1 Market Size & Forecasts and Trend Analysis, By Patch Type, 2015 to 2026 (USD Million)
7.4.5.3.2 Market Size & Forecasts and Trend Analysis, By Distribution Type, 2015 to 2026 (USD Million)
7.4.5.4 UAE
7.4.5.4.1 Market Size & Forecasts and Trend Analysis, By Patch Type, 2015 to 2026 (USD Million)
7.4.5.4.2 Market Size & Forecasts and Trend Analysis, By Type, 2015 to 2026 (USD Million)
Chapter 8 Company Profiles
8.1 Company Profiles
8.1.1 Acorda Therapeutics
8.1.1.1 Company overview
8.1.1.2 Financial Performance
8.1.1.3 Product benchmarking
8.1.1.4 Strategic initiatives
8.1.2 Glaxo SmithKline Plc
8.1.2.1 Company overview
8.1.2.2 Financial Performance
8.1.2.3 Product benchmarking
8.1.2.4 Strategic initiatives
8.1.3 IBSA Institut Biochimique SA
8.1.3.1 Company overview
8.1.3.2 Financial Performance
8.1.3.3 Product benchmarking
8.1.3.4 Strategic initiatives
8.1.4 Teva Pharmaceuticals Industries Ltd.
8.1.4.1 Company overview
8.1.4.2 Financial Performance
8.1.4.3 Product benchmarking
8.1.4.4 Strategic initiatives
8.1.5 Teikoku seiyaku Co. Ltd.
8.1.5.1 Company overview
8.1.5.2 Financial Performance
8.1.5.3 Product benchmarking
8.1.5.4 Strategic initiatives
8.1.6 TEH SENG Pharmaceutical Mfg Co
8.1.6.1 Company overview
8.1.6.2 Financial Performance
8.1.6.3 Product benchmarking
8.1.6.4 Strategic initiatives
8.1.7 Richmar, Inc.
8.1.7.1 Company overview
8.1.7.2 Financial Performance
8.1.7.3 Product benchmarking
8.1.7.4 Strategic initiatives
8.1.8 Endo Pharmaceuticals
8.1.8.1 Company overview
8.1.8.2 Financial Performance
8.1.8.3 Product benchmarking
8.1.8.4 Strategic initiatives
8.1.9 Hisamitsu Pharmaceutical Co. Inc.
8.1.9.1 Company overview
8.1.9.2 Financial Performance
8.1.9.3 Product benchmarking
8.1.9.4 Strategic initiatives
8.1.10 Mylan N.V.
8.1.10.1 Company overview
8.1.10.2 Financial Performance
8.1.10.3 Product benchmarking
8.1.10.4 Strategic initiatives
List of Tables Table 1 List of key distributors and channel partners Table 2 List of key emerging companies'/Product disruptors/innovators Table 3 North America Non-opioid Pain Patches Market, by countries, 2015 - 2026 (USD Million) Table 4 North America Non-opioid Pain Patches Market, by Patch Type, 2015 - 2026 (USD Million) Table 5 North America Non-opioid Pain Patches Market, by distribution, 2015 - 2026 (USD Million) Table 6 U.S. Non-opioid Pain Patches Market, by Patch Type, 2015 - 2026 (USD Million) Table 7 U.S. Non-opioid Pain Patches Market, by distribution, 2015 - 2026 (USD Million) Table 8 Canada Non-opioid Pain Patches Market, by Patch Type, 2015 - 2026 (USD Million) Table 9 Canada Non-opioid Pain Patches Market, by distribution, 2015 - 2026 (USD Million) Table 10 Europe Non-opioid Pain Patches Market, by Patch Type, 2015 - 2026 (USD Million) Table 11 Europe Non-opioid Pain Patches Market, by distribution, 2015 - 2026 (USD Million) Table 12 UK Non-opioid Pain Patches Market, by Patch Type, 2015 - 2026 (USD Million) Table 13 UK Non-opioid Pain Patches Market, by distribution, 2015 - 2026 (USD Million) Table 14 Germany Non-opioid Pain Patches Market, by Patch Type, 2015 - 2026 (USD Million) Table 15 Germany Non-opioid Pain Patches Market, by distribution, 2015 - 2026 (USD Million) Table 16 France Non-opioid Pain Patches Market, by Patch Type, 2015 - 2026 (USD Million) Table 17 France Non-opioid Pain Patches Market, by distribution, 2015 - 2026 (USD Million) Table 18 France Non-opioid Pain Patches Market, by application, 2015 - 2026 (USD Million) Table 19 France Non-opioid Pain Patches Market, by end use, 2015 - 2026 (USD Million) Table 20 Italy Non-opioid Pain Patches Market, by Patch Type, 2015 - 2026 (USD Million) Table 21 Italy Non-opioid Pain Patches Market, by distribution, 2015 - 2026 (USD Million) Table 22 Spain Non-opioid Pain Patches Market, by Patch Type, 2015 - 2026 (USD Million) Table 23 Spain Non-opioid Pain Patches Market, by distribution, 2015 - 2026 (USD Million) Table 24 Russia Non-opioid Pain Patches Market, by Patch Type, 2015 - 2026 (USD Million) Table 25 Russia Non-opioid Pain Patches Market, by distribution, 2015 - 2026 (USD Million) Table 26 Asia Pacific Non-opioid Pain Patches Market, by Patch Type, 2015 - 2026 (USD Million) Table 27 Asia Pacific Non-opioid Pain Patches Market, by distribution, 2015 - 2026 (USD Million) Table 28 Japan Non-opioid Pain Patches Market, by Patch Type, 2015 - 2026 (USD Million) Table 29 Japan Non-opioid Pain Patches Market, by distribution, 2015 - 2026 (USD Million) Table 30 China Non-opioid Pain Patches Market, by Patch Type, 2015 - 2026 (USD Million) Table 31 China Non-opioid Pain Patches Market, by distribution, 2015 - 2026 (USD Million) Table 32 India Non-opioid Pain Patches Market, by Patch Type, 2015 - 2026 (USD Million) Table 33 India Non-opioid Pain Patches Market, by distribution, 2015 - 2026 (USD Million) Table 34 South Korea Non-opioid Pain Patches Market, by Patch Type, 2015 - 2026 (USD Million) Table 35 South Korea Non-opioid Pain Patches Market, by distribution, 2015 - 2026 (USD Million) Table 36 Australia Non-opioid Pain Patches Market, by Patch Type, 2015 - 2026 (USD Million) Table 37 Australia Non-opioid Pain Patches Market, by distribution, 2015 - 2026 (USD Million) Table 38 Latin America Non-opioid Pain Patches Market, by Patch Type, 2015 - 2026 (USD Million) Table 39 Latin America Non-opioid Pain Patches Market, by distribution, 2015 - 2026 (USD Million) Table 40 Brazil Non-opioid Pain Patches Market, by Patch Type, 2015 - 2026 (USD Million) Table 41 Brazil Non-opioid Pain Patches Market, by distribution, 2015 - 2026 (USD Million) Table 42 Mexico Non-opioid Pain Patches Market, by Patch Type, 2015 - 2026 (USD Million) Table 43 Mexico Non-opioid Pain Patches Market, by distribution, 2015 - 2026 (USD Million) Table 44 Argentina Non-opioid Pain Patches Market, by Patch Type, 2015 - 2026 (USD Million) Table 45 Argentina Non-opioid Pain Patches Market, by distribution, 2015 - 2026 (USD Million) Table 46 MEA Non-opioid Pain Patches Market, by Patch Type, 2015 - 2026 (USD Million) Table 47 MEA Non-opioid Pain Patches Market, by distribution, 2015 - 2026 (USD Million) Table 48 South Africa Non-opioid Pain Patches Market, by Patch Type, 2015 - 2026 (USD Million) Table 49 South Africa Non-opioid Pain Patches Market, by distribution, 2015 - 2026 (USD Million) Table 50 Saudi Arabia Non-opioid Pain Patches Market, by Patch Type, 2015 - 2026 (USD Million) Table 51 Saudi Arabia Non-opioid Pain Patches Market, by distribution, 2015 - 2026 (USD Million) Table 52 UAE Non-opioid Pain Patches Market, by Patch Type, 2015 - 2026 (USD Million) Table 53 UAE Non-opioid Pain Patches Market, by distribution, 2015 - 2026 (USD Million)
List of Figures Fig. 1 Non-opioid Pain Patches Market segmentation Fig. 2 Market research process Fig. 3 Information procurement Fig. 4 Primary research pattern Fig. 5 Market research approaches Fig. 6 Value chain based sizing & forecasting Fig. 7 Non-opioid Pain Patches Market snapshot (2018) Fig. 8 Non-opioid Pain Patches Market: Segment snapshot (2018) Fig. 9 Competitive Insights (2018) Fig. 10 Parent market outlook Fig. 11 Related/ancillary market outlook Fig. 12 Penetration and growth prospect mapping Fig. 13 Industry value chain analysis Fig. 14 Non-opioid Pain Patches Market driver impact Fig. 15 Non-opioid Pain Patches Market restraint impact Fig. 16 Porter's Five Forces Analysis Fig. 17 SWOT Analysis, By Factor (Political & legal Economic and technological) Fig. 18 Strategic alliance analysis Fig. 19 Recent developments & impact analysis, by key market participants Fig. 20 Key company market share analysis, 2018 Fig. 21 Company market share/ranking, by region Fig. 22 Company market position analysis Fig. 23 Definition and scope, by Patch Type Fig. 24 Patch Type market share analysis, 2018 & 2026 Fig. 25 Segment dashboard Fig. 26 Global Non-opioid Pain Patches Market, by Patch Type, 2015-2026 (USD Million) Fig. 27 Global Consumables market, 2015 - 2026 (USD Million) Fig. 28 Global Software and Services market, 2015 - 2026 (USD Million) Fig. 29 Global Instruments market, 2015 - 2026 (USD Million) Fig. 30 Global Non-opioid Pain Patches Market, by Type market, 2015 - 2026 (USD Million) Fig. 31 Global Lidocaine Patches market, 2015 - 2026 (USD Million) Fig. 32 Global Diclofenac Patches market, 2015 - 2026 (USD Million) Fig. 33 Global Methyl Salicylate Patches market, 2015 - 2026 (USD Million) Fig. 34 Global Capsaicin Patches market, 2015 - 2026 (USD Million) Fig. 35 Global Ketoprofen Patches market, 2015 - 2026 (USD Million) Fig. 36 Global Non-opioid Pain Patches Market, by Distribution type market, 2015 - 2026 (USD Million) Fig. 37 Global Hospital Pharmacies market, 2015 - 2026 (USD Million) Fig. 38 Global Online Pharmacies market, 2015 - 2026 (USD Million) Fig. 39 Global Drug Stores market, 2015 - 2026 (USD Million) Fig. 40 North America Non-opioid Pain Patches Market share analysis by country, 2018 Fig. 41 Europe Non-opioid Pain Patches Market share analysis by country, 2018 Fig. 42 Asia Pacific Non-opioid Pain Patches Market share analysis by country, 2018 Fig. 43 Latin America Non-opioid Pain Patches Market share analysis by country, 2018 Fig. 44 Middle East and Africa Non-opioid Pain Patches Market share analysis by country, 2018 Fig. 45 North America SWOT analysis, by factor (political & legal, economic and technological) Fig. 46 Europe SWOT analysis, by factor (political & legal, economic and technological) Fig. 47 Asia Pacific SWOT analysis, by factor (political & legal, economic and technological) Fig. 48 Latin America SWOT analysis, by factor (political & legal, economic and technological) Fig. 49 Middle East and Africa SWOT analysis, by factor (political & legal, economic and technological)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
